Click on the company or penalty amount for more information on each case. Click on the current parent name to reach the summary page for that parent company.
Company | Current Parent | Current Parent Industry | Primary Offense Type | Year | Agency | Penalty Amount |
---|---|---|---|---|---|---|
Pfizer Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2002 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $21,084,700 |
Pfizer, Inc. | Pfizer | pharmaceuticals | kickbacks and bribery | 2009 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $331,485,170 |
Purdue Pharma | Purdue Pharma | pharmaceuticals | off-label or unapproved promotion of medical products | 2007 | MULTI-AG | $19,500,000 |
SmithKline Beecham Corp. | GlaxoSmithKline | pharmaceuticals | price-fixing or anti-competitive practices | 2005 | MULTI-AG | $10,000,000 |
Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2000 | MULTI-AG | $17,551,650 |
TAP Pharmaceutical Products, Inc. | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2001 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $25,516,440 |
Teva Pharmaceuticals Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MULTI-AG | $169,000,000 |
UCB Pharma, Inc. | UCB | pharmaceuticals | price-fixing or anti-competitive practices | 2009 | MULTI-AG | $2,275,454 |
Warner Chilcott Holdings | AbbVie | pharmaceuticals | price-fixing or anti-competitive practices | 2007 | MULTI-AG | $5,500,000 |
Warner-Lambert | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2004 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $190,000,000 |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | MULTI-AG | $70,000,000 |
Wyeth Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | False Claims Act and related | 2016 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $371,351,180 |
Wyeth Pharmaceuticals, Inc. | Pfizer | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $257,400,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | drug or medical equipment safety violation | 2019 | MULTI-AG | $116,860,000 |
Novartis Pharmaceuticals Corp. | Novartis | pharmaceuticals | kickbacks and bribery | 2020 | MULTI-AG | $103,000,000 |
Pacira Pharmaceuticals, Inc. | Pacira BioSciences | pharmaceuticals | kickbacks and bribery | 2020 | MULTI-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $3,500,000 |
Bristol Myers Squibb Co. | Bristol-Myers Squibb | pharmaceuticals | False Claims Act and related | 2021 | MULTI-AG | $75,000,000 |
Indivior Inc. | Indivior PLC | pharmaceuticals | price-fixing or anti-competitive practices | 2023 | MULTI-AG | $102,500,000 |
Dey LP | Viatris | pharmaceuticals | False Claims Act and related | 2007 | MT-AG | $198,000 |
Janssen Ortho LLC and Janssen Pharmaceuticals, Inc. | Johnson & Johnson | pharmaceuticals | off-label or unapproved promotion of medical products | 2014 | MT-AG | $5,900,000 |
Alere Inc. | Abbott Laboratories | pharmaceuticals | kickbacks and bribery | 2017 | MS-AG | $2,000,000 |
Alpharma USPD, Inc., | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Dey Labs | Viatris | pharmaceuticals | False Claims Act and related | 2009 | MS-AG | $3,900,000 |
Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | MS-AG | $18,500,000 |
Par Pharmaceutical Co. | Endo International | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Purepac Pharmaceutical Co., n/k/a Actavis Elizabeth, LLC | Pfizer | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $2,010,667 |
Sandoz, Inc. | Sandoz Group | pharmaceuticals | False Claims Act and related | 2011 | MS-AG | $30,110,618 |
Watson, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2018 | MS-AG | $33,408,547 |
Dey Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2006 | MO-AG | $2,932,000 |
Roxane, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2010 | MO-AG | $3,100,000 |
Schering-Plough | Merck | pharmaceuticals | False Claims Act and related | 2008 | MO-AG | $31,000,000 |
Teva Pharmaceuticals USA | Teva Pharmaceutical Industries | pharmaceuticals | environmental violation | 2013 | MO-AG | (*)Penalty amounts marked by an asterisk are ones announced by more than one agency. Parent penalty totals are adjusted to avoid double-counting. $2,402,793 |
Teva Pharmaceuticals USA Inc. | Teva Pharmaceutical Industries | pharmaceuticals | environmental violation | 2003 | MO-AG | $70,000 |
Allergan Inc | AbbVie | pharmaceuticals | wage and hour violation | 2019 | MI-LEO | $7,656 |
Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | pharmaceuticals | wage and hour violation | 2018 | MI-LEO | $12,500 |
Otsuka American Pharmaceutical Inc | Otsuka Pharmaceutical | pharmaceuticals | wage and hour violation | 2018 | MI-LEO | $5,070 |
Allergan Usa Inc | AbbVie | pharmaceuticals | wage and hour violation | 2017 | MI-LEO | $64,828 |
Allergan Plc | AbbVie | pharmaceuticals | wage and hour violation | 2016 | MI-LEO | $73,999 |
Allergan Usa Inc | AbbVie | pharmaceuticals | wage and hour violation | 2016 | MI-LEO | $73,999 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | wage and hour violation | 2014 | MI-LEO | $13,000 |
Novartis Pharmaceuticals Corporation | Novartis | pharmaceuticals | wage and hour violation | 2014 | MI-LEO | $5,885 |
AMGEN INC | Amgen | pharmaceuticals | environmental violation | 2006 | MA-ENV | $11,600 |
ANIKA THERAPEUTICS INC | Anika Therapeutics | pharmaceuticals | environmental violation | 2003 | MA-ENV | $15,500 |
AMGEN INC | Amgen | pharmaceuticals | environmental violation | 2002 | MA-ENV | $15,000 |
BRISTOL-MYERS SQUIBB | Bristol-Myers Squibb | pharmaceuticals | environmental violation | 2023 | MA-ENV | $11,615 |
General Nutrition Corporation | Harbin Pharmaceutical Group | pharmaceuticals | wage and hour violation | 2017 | MA-AG | $72,304 |
Actavis Elizabeth LLC | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $3,600,000 |
Amphastar Pharmaceuticals, Inc. | Amphastar Pharmaceuticals | pharmaceuticals | price-fixing or anti-competitive practices | 2015 | MA-AG | $325,000 |
Barr Laboratories, Inc. and Duramed Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2007 | MA-AG | $2,000,000 |
Boehringer Ingelheim Roxane, Inc. | Hikma Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2008 | MA-AG | $1,800,000 |
Daiichi Pharmaceutical | Daiichi Sankyo | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2007 | MA-AG | $2,900,000 |
Eisai Co. | Eisai | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Hoffman-LaRoche | Roche | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Merck & Co., Inc. | Merck | pharmaceuticals | False Claims Act and related | 2011 | MA-AG | $24,000,000 |
Mylan Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $2,600,000 |
Par Pharmaceutical, Inc. | Endo International | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $500,000 |
Takeda Chemical | Takeda Pharmaceutical | pharmaceuticals | price-fixing or anti-competitive practices | 2002 | MA-AG | $111,167 |
Teva Pharmaceutical USA, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2009 | MA-AG | $7,000,000 |
Watson Pharmaceuticals, Inc. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2010 | MA-AG | $2,400,000 |
Shire Human Genetic Therapies, Inc. | Takeda Pharmaceutical | pharmaceuticals | environmental violation | 2021 | MA-AG | $600,000 |
Abbott Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $6,200,000 |
Actavis | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $4,000,000 |
Apotex | Apotex Corp. | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
Astellas | Astellas Pharma | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,130,000 |
Aventis | Sanofi | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Biovail | Bausch Health | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $200,000 |
Boehringer Ingelheim | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $3,250,000 |
Dey | Viatris | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $3,000,000 |
Eisai | Eisai | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,000,000 |
Eli Lilly | Eli Lilly | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $1,650,000 |
Eli Lilly | Eli Lilly | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | LA-AG | $20,000,000 |
Forest Laboratories | AbbVie | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,000,000 |
Gilead Sciences | Gilead Sciences | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $250,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $10,000,000 |
Johnson & Johnson | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $10,000,000 |
Lupin Pharmaceuticals | Lupin Limited | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $750,000 |
Novartis | Novartis | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $7,000,000 |
Par Pharmaceutical | Endo International | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $6,000,000 |
Pernix Therapeutics | Currax Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $800,000 |
Perrigo | Perrigo | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $2,000,000 |
Ranbaxy | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
Sandoz | Sandoz Group | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $13,100,000 |
Schering-Plough | Merck | pharmaceuticals | False Claims Act and related | 2012 | LA-AG | $5,000,000 |
Shire | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $4,000,000 |
Takeda/Tap Pharmaceuticals | Takeda Pharmaceutical | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,750,000 |
Taro Pharmaceutical Industries | Sun Pharmaceuticals | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $5,000,000 |
UCB | UCB | pharmaceuticals | False Claims Act and related | 2013 | LA-AG | $3,350,000 |
Alpharma USPD, Inc. and Purepac Pharmaceutical Co. | Teva Pharmaceutical Industries | pharmaceuticals | False Claims Act and related | 2011 | KY-AG | $10,200,000 |
Amgen, Inc. | Amgen | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $2,400,000 |
AstraZeneca | AstraZeneca | pharmaceuticals | off-label or unapproved promotion of medical products | 2013 | KY-AG | $5,500,000 |
AstraZeneca | AstraZeneca | pharmaceuticals | consumer protection violation | 2010 | KY-AG | $5,391,000 |
AstraZeneca | AstraZeneca | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $14,700,000 |
Aventis Pharmaceuticals, Inc. and Aventis Behring, LLC | Sanofi | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $2,290,000 |
Boehringer Ingelheim Pharmaceuticals, Inc., Boehringer Ingelheim Roxane, Inc., Roxane Laboratories, Inc. and Ben Venue Laboratories, Inc. | Boehringer Ingelheim | pharmaceuticals | False Claims Act and related | 2009 | KY-AG | $4,500,000 |
Dey, Inc. | Viatris | pharmaceuticals | False Claims Act and related | 2010 | KY-AG | $3,500,000 |
Forest Pharmaceuticals Inc. | AbbVie | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $1,750,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2010 | KY-AG | $3,700,000 |
GlaxoSmithKline | GlaxoSmithKline | pharmaceuticals | off-label or unapproved promotion of medical products | 2009 | KY-AG | $661,860 |
Janssen Pharmaceutical Products, LP, Centocor, Inc., McNeil Pharmaceutical, Inc., Ortho Biotech Products, LP and Ortho-McNeil Pharmaceutical, Inc. | Johnson & Johnson | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $7,000,000 |
Merck Sharp & Dohme Corp. | Merck | pharmaceuticals | False Claims Act and related | 2012 | KY-AG | $6,000,000 |